DOJ – Page 19 – Policy & Medicine

An FCA Journey – Allergan to Pay $53M to DOJ

Quest to Pay $6 Million to Settle Kickback and Unnecessary Testing Allegations

Novo Nordisk Settles Qui Tam Suit

Mylan Settlement Classified as “Too Low”

DOJ Has Third Highest Annual Recovery in FCA History

Bristol-Myers Squibb Settles Off-Label Promotion Case for $19.5 Million

Sanofi Settles Vaccine Antitrust Dispute

Former Tenet Healthcare Executive Charged

Department of Justice Increases FCA Civil Penalties, Again

Zimmer Biomet Pays $30 Million to Resolve New FCPA Charges